首页> 外文OA文献 >Genome-wide enhancer prediction from epigenetic signatures using genetic algorithm-optimized support vector machines
【2h】

Genome-wide enhancer prediction from epigenetic signatures using genetic algorithm-optimized support vector machines

机译:使用遗传算法优化的支持向量机根据表观遗传特征预测全基因组增强子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The chemical modification of histones at specific DNA regulatory elements is linked to the activation, inactivation and poising of genes. A number of tools exist to predict enhancers from chromatin modification maps, but their practical application is limited because they either (i) consider a smaller number of marks than those necessary to define the various enhancer classes or (ii) work with an excessive number of marks, which is experimentally unviable. We have developed a method for chromatin state detection using support vector machines in combination with genetic algorithm optimization, called ChromaGenSVM. ChromaGenSVM selects optimum combinations of specific histone epigenetic marks to predict enhancers. In an independent test, ChromaGenSVM recovered 88% of the experimentally supported enhancers in the pilot ENCODE region of interferon gamma-treated HeLa cells. Furthermore, ChromaGenSVM successfully combined the profiles of only five distinct methylation and acetylation marks from ChIP-seq libraries done in human CD4+ T cells to predict ∼21 000 experimentally supported enhancers within 1.0 kb regions and with a precision of ∼90%, thereby improving previous predictions on the same dataset by 21%. The combined results indicate that ChromaGenSVM comfortably outperforms previously published methods and that enhancers are best predicted by specific combinations of histone methylation and acetylation marks.
机译:组蛋白在特定DNA调控元件上的化学修饰与基因的激活,失活和平衡相关。有许多工具可从染色质修饰图上预测增强子,但它们的实际应用受到限制,因为它们要么(i)考虑的标记数量少于定义各种增强剂类别所需的标记数量,要么(ii)使用过多数量的标记。标记,这在实验上是不可行的。我们已经开发了一种使用支持​​向量机结合遗传算法优化的染色质状态检测方法,称为ChromaGenSVM。 ChromaGenSVM选择特定组蛋白表观遗传标记的最佳组合来预测增强子。在一项独立测试中,ChromaGenSVM在干扰素伽马处理的HeLa细胞的先导ENCODE区域中回收了88%实验支持的增强子。此外,ChromaGenSVM成功地结合了在人类CD4 + T细胞中完成的ChIP-seq库中仅有的五个不同的甲基化和乙酰化标记的谱图,从而预测了在1.0µkb区域内〜21 000个实验支持的增强子,其精确度约为90%,从而改善了以前的同一数据集上的预测减少了21%。合并的结果表明,ChromaGenSVM舒适地胜过了以前发表的方法,并且通过组蛋白甲基化和乙酰化标记的特定组合可以最好地预测增强子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号